<DOC>
	<DOCNO>NCT00285376</DOCNO>
	<brief_summary>This study design determine safety effectiveness vilazodone major depressive disorder discover genetic marker associate response . This study enroll approximately 400 patient .</brief_summary>
	<brief_title>Effectiveness Study Vilazodone Treat Depression Discover Genetic Markers Associated With Response</brief_title>
	<detailed_description>This randomize , double-blind , placebo-controlled , multicenter , 8-week , clinical trial design assess efficacy safety vilazodone discover genetic marker treatment response associate vilazodone use adult patient diagnose MDD DSM-IV-TR criterion . This study enroll approximately 400 patient .</detailed_description>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Vilazodone Hydrochloride</mesh_term>
	<criteria>Male female patient 1865 year age , inclusive . A diagnosis MDD , single episode recurrent , accord DSMIVTR ( 296.2/296.3 ) current Major Depressive Episode less two year 's duration minimum duration least 4 week . HAMD score ≥ 22 . HAMD item 1 ( depressed mood ) score ≥ 2 . Patients must able provide write informed consent participate begin trial related activity . Patients must able speak , read understand English posse ability respond question follow simple instruction . A current ( within 6 month prior Screening Visit ) Axis I disorder Post Traumatic Stress Disorder , Eating Disorder , Obsessive Compulsive Disorder ( Generalized Anxiety Disorder , Social Phobia Simple Phobia allow ) . A history schizophrenia , schizoaffective disorder bipolar I II disorder ( history hypomanic manic episode ) . DSMIVTR criterion substance abuse ( alcohol drug ) within 3 month prior Screening Visit substance dependence within 6 month prior Screening Visit . Criteria follow DSMIVTR MDD Specifiers : [ ] With Catatonic Features ; [ b ] With Postpartum Onset ; [ c ] With Seasonal Pattern .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>Depression . Genetics , Pharmacogenetics</keyword>
</DOC>